The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
ICON8: An international randomized trial comparing two dose-dense regimens, 3-weekly carboplatin plus weekly paclitaxel (CwT), and weekly carboplatin-paclitaxel (wCwT), to standard 3-weekly treatment in women with newly diagnosed ovarian, fallopian tube, and primary peritoneal cancer.
Jane Hook
No relevant relationships to disclose
Sally Patricia Stenning
Research Funding - Medical Research Council
James Brenton
No relevant relationships to disclose
Stan B Kaye
No relevant relationships to disclose
Iain A. McNeish
Research Funding - Cancer Research UK; Medical Research Council
Raj Naik
No relevant relationships to disclose
Timothy Perren
No relevant relationships to disclose
Jennifer Petrie
No relevant relationships to disclose
Laura Farrelly
No relevant relationships to disclose
Andrew Peter Dean
No relevant relationships to disclose
Dearbhaile M. O'Donnell
No relevant relationships to disclose
Dolores Gallardo Rincon
No relevant relationships to disclose
Jae Weon Kim
No relevant relationships to disclose
Jonathan A. Ledermann
No relevant relationships to disclose
Andrew R. Clamp
No relevant relationships to disclose